Laporan Laba Rugi ABOT - TTM - Abbott Laboratories (Pakistan) Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Abbott Laboratories (Pakistan) Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	32,847	35,283	37,113	39,548	41,759	42,570	44,450	46,452	48,074	49,258	51,292	51,820	53,531	55,475	57,698	60,432	63,814	68,177	69,495	72,385
Change (%)		7.42	5.18	6.56	5.59	1.94	4.42	4.50	3.49	2.46	4.13	1.03	3.30	3.63	4.01	4.74	5.60	6.84	1.93	4.16
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	22,022	23,499	24,377	25,286	26,503	26,554	28,146	30,213	32,089	34,821	37,730	40,040	42,882	43,715	44,695	46,157	46,288	48,283	48,210	48,196
Change (%)		6.71	3.74	3.73	4.82	0.19	5.99	7.35	6.21	8.51	8.35	6.12	7.10	1.94	2.24	3.27	0.28	4.31	-0.15	-0.03
% of Revenue	67.04	66.60	65.68	63.94	63.47	62.38	63.32	65.04	66.75	70.69	73.56	77.27	80.11	78.80	77.46	76.38	72.54	70.82	69.37	66.58

Gross Operating Profit	10,825	11,784	12,736	14,262	15,255	16,015	16,305	16,239	15,985	14,436	13,563	11,780	10,650	11,760	13,003	14,275	17,526	19,894	21,285	24,189
Change (%)		8.86	8.07	11.99	6.96	4.98	1.81	-0.40	-1.56	-9.69	-6.05	-13.14	-9.60	10.43	10.57	9.78	22.78	13.51	6.99	13.64
% of Revenue	32.96	33.40	34.32	36.06	36.53	37.62	36.68	34.96	33.25	29.31	26.44	22.73	19.89	21.20	22.54	23.62	27.46	29.18	30.63	33.42

SG&A	5,484	5,516	5,926	6,385	6,809	7,232	7,426	7,744	7,903	7,835	8,125	8,441	8,691	8,989	9,341	9,622	10,003	10,362	10,720	11,255
Change (%)		0.58	7.43	7.75	6.64	6.20	2.68	4.29	2.05	-0.86	3.70	3.88	2.97	3.43	3.92	3.01	3.96	3.59	3.46	4.99
% of Revenue	16.70	15.63	15.97	16.15	16.31	16.99	16.71	16.67	16.44	15.91	15.84	16.29	16.24	16.20	16.19	15.92	15.68	15.20	15.43	15.55

R&D
Change (%)
% of Revenue

OpEx	27,910	29,618	30,788	32,289	33,926	34,564	36,429	38,700	40,726	43,247	46,312	48,793	51,774	53,007	54,468	56,283	57,040	59,508	59,982	60,694
Change (%)		6.12	3.95	4.88	5.07	1.88	5.40	6.23	5.24	6.19	7.09	5.36	6.11	2.38	2.76	3.33	1.35	4.33	0.80	1.19
% of Revenue	84.97	83.94	82.96	81.65	81.24	81.19	81.96	83.31	84.72	87.80	90.29	94.16	96.72	95.55	94.40	93.13	89.38	87.28	86.31	83.85

Operating Income	4,937	5,666	6,325	7,259	7,833	8,006	8,021	7,752	7,348	6,011	4,981	3,028	1,757	2,468	3,230	4,149	6,774	8,669	9,513	11,692
Change (%)		14.75	11.64	14.76	7.91	2.21	0.18	-3.35	-5.22	-18.19	-17.14	-39.21	-41.97	40.45	30.88	28.45	63.29	27.97	9.73	22.91
% of Revenue	15.03	16.06	17.04	18.35	18.76	18.81	18.04	16.69	15.28	12.20	9.71	5.84	3.28	4.45	5.60	6.87	10.62	12.72	13.69	16.15

Interest Expense	-50	-70	-82	-83	-79	-54	-44	-42	-42	-25	-20	-14	-12	-22	-20	-18	-17	-12	-9	-37
Change (%)		41.83	16.49	1.70	-4.83	-31.35	-18.78	-6.13	1.47	-39.70	-23.14	-27.21	-18.76	91.99	-10.85	-9.73	-6.19	-29.89	-23.12	308.24
% of Revenue	-0.15	-0.20	-0.22	-0.21	-0.19	-0.13	-0.10	-0.09	-0.09	-0.05	-0.04	-0.03	-0.02	-0.04	-0.03	-0.03	-0.03	-0.02	-0.01	-0.05

Net Income	3,633	4,535	5,115	5,697	5,922	5,967	5,966	4,465	4,040	3,004	1,343	425	-353	262	2,000	3,201	5,004	5,234	5,315	6,637
Change (%)		24.83	12.79	11.38	3.94	0.77	-0.01	-25.16	-9.52	-25.64	-55.30	-68.37	-183.21	-174.05	664.03	60.06	56.30	4.61	1.55	24.87
% of Revenue	11.06	12.85	13.78	14.41	14.18	14.02	13.42	9.61	8.40	6.10	2.62	0.82	-0.66	0.47	3.47	5.30	7.84	7.68	7.65	9.17

Source: Capital IQ

Abbott Laboratories (Pakistan) Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)